In the human melanoma A375 cell line, EGCG inhibited growth through the activation of the apoptotic pathway, with an increase in the pro-apoptotic protein caspase 3 and with a decrease in the anti-apoptotic protein BCl-2. Here, BCL2 is linked to melanoma.